mTOR, a protein receives signals from cell division process
through internal sensors that measures nutrients and energy supply and directs
the cell to take action. These molecular switch studies were applied on heart
disorders like overworked heart (enlarging). It is also have
applications in diabetes, kidney and lung disease, cancer and autoimmune
disorders.
The protein mTOR, stands for mechanistic
target of rapamycin, is so important to normal cells yet also plays
major roles in several diseases. It combines with other proteins to form a
complex, the major one being known as mTORC1. Superiorly active mTORC1 is known
to be bad for the heart and leads to damage and disease, and it is thought that
having control over mTORC1 protein could effectively treat heart disease.
Overworked hearts with too much active mTORC1 enlarge abnormally similar to
body muscle that bulks up after carrying heavy weights.
There is another protein called Protein Kinase G, which
protects heart tissue from damage and disease. The surprising discovery of
scientists’ that is the protein kinase G blocked mTORC1, figured out the key
regulator of mTORC1 called tuberin (dubbed TCS2 by researchers), which acts
like an "antenna" for biochemical signals triggering or blocking cell
growth, and regulating metabolism. Similar to many other proteins known to
alter tuberin, Ranek found protein kinase G altered tuberin by adding phosphates
to it, but in a previously unpredicted region that turned out to provide the
sought after brake-like effect. Protein kinase G is also the target of drugs
like sildenafil which
is commonly known as Viagra.
No comments:
Post a Comment